Evidera
Gabriel Lemyre is a Research Associate III at Evidera since June 2021, having previously held the position of Research Associate II. At Université de Montréal, Lemyre served as an Ambassador for the admissions and recruitment service from January 2021 to February 2024, engaging with prospective students and participating in promotional activities. Lemyre's experience also includes various teaching assistant roles in financial mathematics, risk theory, and financial derivatives. Prior internships in risk management at CDPQ and machine learning consulting at Desjardins contributed to the professional skill set. Lemyre holds a Master's degree in Applied Mathematics and a Bachelor's degree in Mathematics with a specialization in Actuarial Science from Université de Montréal, along with a DEC in Pure and Applied Sciences from Cégep de Saint-Hyacinthe.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.